RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade.
Leukemia
; 34(4): 1017-1026, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31740809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Virus
/
RNA, Double-Stranded
/
Leukemia, Myeloid, Acute
/
Antibodies, Neutralizing
/
DEAD Box Protein 58
/
Immunotherapy
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
Germany